A. SANRI Et Al. , "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia," 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017 , 2017
SANRI, A. Et Al. 2017. Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia. 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017 .
SANRI, A., özyılmaz, b., MUTLU ALBAYRAK, H., ALTUNDAĞ, E., KARADAĞ ALPASLAN, M., Can Yılmaz, G., ... kara, c.(2017). Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia . 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017
SANRI, ASLIHAN Et Al. "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia," 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017, 2017
SANRI, ASLIHAN Et Al. "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia." 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017 , 2017
SANRI, A. Et Al. (2017) . "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia." 2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017 .
@conferencepaper{conferencepaper, author={ASLIHAN SANRI Et Al. }, title={Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia}, congress name={2. EGE ENDOKRİN HASTALIKLAR VE GENETİK SEMPOZYUMU 23-25 ŞUBAT 2017}, city={}, country={}, year={2017}}